Rite Aid Shares Outstanding 2010-2022 | RAD

Rite Aid shares outstanding from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Rite Aid Annual Shares Outstanding
(Millions of Shares)
2022 54
2021 54
2020 53
2019 53
2018 52
2017 53
2016 52
2015 51
2014 49
2013 45
2012 44
2011 44
2010 44
2009 42
Rite Aid Quarterly Shares Outstanding
(Millions of Shares)
2022-08-31 55
2022-05-31 54
2022-02-28 54
2021-11-30 54
2021-08-31 54
2021-05-31 54
2021-02-28 54
2020-11-30 54
2020-08-31 54
2020-05-31 53
2020-02-29 53
2019-11-30 54
2019-08-31 53
2019-05-31 53
2019-02-28 53
2018-11-30 53
2018-08-31 53
2018-05-31 53
2018-02-28 52
2017-11-30 53
2017-08-31 53
2017-05-31 52
2017-02-28 53
2016-11-30 53
2016-08-31 53
2016-05-31 52
2016-02-29 53
2015-11-30 53
2015-08-31 52
2015-05-31 50
2015-02-28 51
2014-11-30 51
2014-08-31 51
2014-05-31 50
2014-02-28 49
2013-11-30 49
2013-08-31 47
2013-05-31 50
2013-02-28 45
2012-11-30 46
2012-08-31 44
2012-05-31 44
2012-02-29 44
2011-11-30 44
2011-08-31 44
2011-05-31 44
2011-02-28 44
2010-11-30 44
2010-08-31 44
2010-05-31 44
2010-02-28 44
2009-11-30 44
2009-08-31 44
2009-05-31 44
2009-02-28 42
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $0.275B $24.568B
Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $125.204B 11.13
Herbalife (HLF) United States $2.145B 5.33
GNC Holdings (GNC) United States $0.000B 0.00